Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214142) titled 'Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: The First Affiliated Hospital of University of Science and Technology of China

Condition: Rectal Cancer Patients

Intervention: Drug: PD-1

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 1, 2025

Target Sample Size: 30

To know more, visit https://clinicaltrials.gov/study/NCT07214142

Published by HT Digital Cont...